Cargando…
MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. The etiology and pathogenesis of HCC remain unclear. Macrophage migration inhibitory factor (MIF) plays a critical role in the pathogenesis of hepatocellular carcinoma. The association between MIF polymorphisms and i...
Autores principales: | Qin, Lifeng, Qin, Jinmei, Lv, Xiaoping, Yin, Caiqiao, Zhang, Qian'e, Zhang, Jiqiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170199/ https://www.ncbi.nlm.nih.gov/pubmed/34093770 http://dx.doi.org/10.3892/ol.2021.12810 |
Ejemplares similares
-
ROCK2 Polymorphism and Expression Contribute to Increased Susceptibility and Poor Prognosis in Hepatocellular Carcinoma
por: Qin, Lifeng, et al.
Publicado: (2022) -
TLR9 Promoter Polymorphism Is Associated with Both an Increased Susceptibility to Gastric Carcinoma and Poor Prognosis
por: Wang, Xiaoyong, et al.
Publicado: (2013) -
Downregulation of PDK4 Increases Lipogenesis and Associates with Poor Prognosis in Hepatocellular Carcinoma
por: Yang, Chen, et al.
Publicado: (2019) -
Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma
por: Qin, Jian, et al.
Publicado: (2018) -
The Role of MIF-173G/C Gene Polymorphism in the Susceptibility of Autoimmune Diseases
por: Du, Xiangrong, et al.
Publicado: (2020)